Evidence map›Paper›PMID 35662213›Full record

ArticleNeural regeneration research2022

Cannabidiol preferentially binds TRPV2: a novel mechanism of action.

Elisa Landucci, Domenico E Pellegrini-Giampietro, Alessandra Gianoncelli, Giovanni Ribaudo

Open access · goldAbstract read
In one paragraph

Article in Neural regeneration research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in neuroinformatics · 2024
    Article
  8. Article
  9. TRPV3: Structure, Diseases and Modulators.Molecules (Basel, Switzerland) · 2023
    Review
  10. Molecules (Basel, Switzerland) · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Elisa LanducciDepartment of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Firenze, Italy.
Domenico E Pellegrini-GiampietroDepartment of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Firenze, Italy.
Alessandra GianoncelliDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
Giovanni RibaudoDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
University of Brescia · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35662213
PMCPMC9165392
OpenAlexW4282946653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.